Schedule 13G ownership disclosure

Capricor Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 14070B309

Event date: 2026-01-16

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 3,399,900.00 · Class: 6.6%

  • KEVIN TANG

    Shares: 3,399,900.00 · Class: 6.6%

  • TANG CAPITAL PARTNERS, LP

    Shares: 2,337,350.00 · Class: 4.5%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 1,062,550.00 · Class: 2.1%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0.0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-26-000831
Form type
SCHEDULE 13G
Filer
CAPRICOR THERAPEUTICS, INC.
CIK
CIK 1133869
Filed
Jan 26, 2026
Reporting period
Jan 16, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub